Drugs / AIDSVAX B/B
re-read 2 minutes ago

AIDSVAX B/B

Developed for
HIV infectious disease
Investigated by
VaxGen

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00002402 HIV infectious disease VaxGen Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AIDSVAX B/B “Arm A: Patients receive 1 of 3 doses of AIDSVAX B/B vaccine (MN rgp120/HIV-1 plus GNE8 rgp120/HIV-1) in alum adjuvant.” NCT00002402
Route Intramuscular “1 or 2 injections into the deltoid muscle” NCT00002402